Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Market Cap$14.37B
Close$
$25.18
23.3% downside
Current Fair Value
23.3% downsideOvervalued by 23.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.37 Billion |
|---|---|
| Enterprise Value | $13.44 Billion |
| Dividend Yield | $0.85 (2.56410256410256%) |
| Earnings per Share | $1.92 |
| Beta | 0.48 |
| Outstanding Shares | 447,628,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.28 |
|---|---|
| PEG | 2.64 |
| Price to Sales | 6.56 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 5.93 |
| Enterprise Value to EBIT | 24.75 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data